Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)-Reference-Cited by-同舟云学术

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

Published:2019-03 Issue:3 Volume:103 Page:605-617
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Dearnaley David,Griffin Clare L.,Lewis Rebecca,Mayles Philip,Mayles Helen,Naismith Olivia F.,Harris Victoria,Scrase Christopher D.,Staffurth John,Syndikus Isabel,Zarkar Anjali,Ford Daniel R.,Rimmer Yvonne L.,Horan Gail,Khoo Vincent,Frew John,Venkitaraman Ramachandran,Hall Emma

Funder

Cancer Research UK

National Institute for Health Research

Accuray

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial;Widmark;Lancet,2009

2. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial;Warde;Lancet,2011

3. Prostate cancer: Elective pelvic nodal radiotherapy: Is the jury still out?;Crook;Nat Rev Urol,2016